26
Apr
South-Southeast: The new growth engine in Asia?
South and Southeast Asia are becoming more attractive for private market investors and have performed reasonably well in the last few years. There is no reason to believe this trend will not continue as LPs seek to diversify their allocations and capitalise on the potential. Many GPs operate in both markets and expanding from one region to another seems like a natural thing to do as there a lot of market similarities. Our experienced panel of investors share their approach to both markets and what are their key ingredients for success.
- What are the similarities between these two markets?
- How difficult is to expand from one market to another?
- Are we seeing more buyout deals done?
- How GPs evolved in these markets?
-
SpeakersSandeep Naik Managing Director, Head of India & Southeast Asia GENERAL ATLANTIC
Gaurav Ahuja Partner CHRYSCAPITAL
Amit Varma Co-Founder and Managing Partner QUADRIA CAPITAL
Rajeev Natarajan Managing Director, Head of Asia Pacific ICONIQ CAPITAL
Sachin Bhanot Head of Southeast Asia Investments PROSUS VENTURES
Bee Chun Boo Principal BAKER MCKENZIE WONG & LEOW
Confirm cancellation
Something went wrong.
An error occurred trying to play the stream. Please reload the page and try again.
CloseSign-up to join the ION Analytics Community to:
- Register for events
- Access market insights
- Download reports
Sandeep Naik is a Managing Director and Head of India & Southeast Asia at General Atlantic, a leading global growth equity firm with $73 billion in assets under management. He is also a member of the firm’s Management and Portfolio Committees. Sandeep serves as a board member at General Atlantic portfolio companies BillDesk, Biofourmis, KFin Technologies Private Limited, PT MAP Boga Adiperkasa (MBA), Rubicon Research, and Mable, as well as serves as a board observer at BYJU’S. He also sits on the Monetary Authority of Singapore’s Financial Centre Advisory Panel and serves as a board member at EDB Singapore.
Before joining General Atlantic in 2012, Sandeep served as a Partner and Co-Head of India for Apax, leading investments in the healthcare, financial and business services, and retail and consumer sectors. Earlier in his career, he was Global Marketing Manager at Medtronic Inc., a scientist at Mayo Clinic, and a management consultant with McKinsey & Company. He is also the Co-Founder of InfraScan Inc., a medical device business focused on detecting bleeding inside the brain using a handheld device. Sandeep was selected as a Young Global Leader by the World Economic Forum and has served on the Global Agenda Council of the New Order of Economic Thinking.
Sandeep holds a B.Tech in Instrumentation Engineering from the University of Mumbai, an M.S. in Biomedical Engineering from the Medical College of Virginia, and an M.B.A. from the Wharton School at the University of Pennsylvania.
Gaurav Ahuja is a Managing Director with ChrysCapital and has been with the firm since 2004. He is responsible for the LP Relations and Fund Raising functions at ChrysCapital. Mr. Ahuja is a member of the Investment Committee and sits on the board of Infogain, ChrysCapital’s IT Services portfolio company. Prior to joining ChrysCapital, he was in the M&A group at Lazard Freres in San Francisco and Merrill Lynch in New York.
Mr. Ahuja received an MBA from INSEAD and a Bachelor’s degree in Commerce and Economics from the University of Virginia.
Dr. Amit Varma is a critical care physician having practiced for almost 30 years in the United States and Asia. He has been on the founding team of large Asian healthcare companies like Narayana Hrudayalaya and Fortis healthcare. He has served on the board of various companies around asia in healthcare delivery, life sciences, medical tech and consumer healthcare including Parkway healthcare in Singapore. He currently co-manages Quadria Capital the largest healthcare focused private equity firm with almost 2 Billion USD in AUM. In addition he has sponsored a dedicated venture healthcare firm HealthQuad with a 200 million USD AUM to work with start ups and early stage companies. He continues to be involved in academics and research and works hard to demystify problems in healthcare.
Dr. Varma is currently the founding managing co-founder of Quadria capital one of the largest healthcare dedicated private equity funds in Asia.
Rajeev Natarajan is the Managing Director and Head of Asia Pacific for ICONIQ Capital, a privately-held investment firm that serves some of the world’s most influential families and organizations. Prior to ICONIQ, Rajeev spent nine years within the Investment Management and Securities Divisions of Goldman Sachs, across the London, Sydney, and Singaporeoffices. He also spent two years in a raw material and commodity trading business in Hong Kong and four years as a Management Consultant with Accenture in their Melbourne and Atlanta offices. Rajeev holds a Bachelor of Commerce and a Bachelor of Arts from Monash University and a Master of Business Administration (MBA) from London Business School.
Sachin Bhanot leads investment efforts in Southeast Asia for Prosus Ventures, based in Singapore. Prior to joining Prosus, Sachin was a member of the investment team at B Capital Group, where he focused on venture investments in Southeast Asia across a range of sectors including consumer & retail, logistics, education, and more. Before that, he was an investment professional at the Abraaj Group and spent time as an analyst at Credit Suisse and the KRA Group. Sachin received a Masters of Engineering in Engineering Science at the University of Oxford.
Bee Chun heads Baker McKenzie’s Energy, Mining & Infrastructure Practice Group in Asia Pacific and co-heads the Mergers and Acquisitions practice in Singapore. She has worked in Baker McKenzie offices in Hong Kong, Shanghai, Taipei and Beijing. Bee Chun practices mainly in the areas of M&A, venture capital and private equity. She was named as one of China's Top 15 Female Lawyers in 2020 by Asian Legal Business (ALB). She is also consistently recognised as a leading lawyer by IFLR1000 in the areas of mergers and acquisitions, private equity and project finance.
Bee Chun has over 23 years of experience in M&A transactions and has represented buyers and sellers from various industries, including financial institution, healthcare, mining, energy and manufacturing. She has also been actively involved in private equity/venture capital transactions, has substantial experience in fund of funds investments, direct investments and the establishment of funds.